Pfizer, Inc.

AI Summary

Pfizer discovers, develops, and sells prescription medicines across multiple areas including heart disease drugs (Eliquis), cancer treatments (Ibrance, Xtandi), vaccines (Prevnar, Abrysvo), and COVID-19 treatment (Paxlovid) [Company Overview]. They also make treatments for rare diseases, immune disorders, and biosimilar versions of other companies' drugs, selling their products in the United States and internationally [Company Overview].

Pfizer is a 175-year-old pharmaceutical giant based in New York that makes and sells medicines, vaccines, and treatments worldwide. The company has a $155.6 billion market cap but is currently facing revenue decline and moderate financial health concerns [Yahoo Finance].

Pfizer generates substantial revenue and cash flow but shows declining sales and moderate financial stress signals.

Recent News

• Pfizer Inc. $PFE Shares Acquired by United Advisor Group LLC

  Watch List News· 2026-04-16

• Here Are Thursday’s Top Wall Street Analyst Research Calls: Autoliv, CoreWeave, Corning, Dicks Sporting Goods, Federated Hermes, Gitlab, PayPal, Pfizer, Okta, and More

  24/7 Wall St· 2026-04-16

• KBC Group NV Purchases 706,426 Shares of Pfizer Inc. $PFE

  The Lincolnian Online· 2026-04-16

• Best Pharmaceutical Stocks To Watch Now – April 15th

  The Lincolnian Online· 2026-04-16

• Lbp Am Sa Has $25.32 Million Holdings in Pfizer Inc. $PFE

  The Lincolnian Online· 2026-04-16

• Pfizer Inc. $PFE Shares Sold by Transcend Capital Advisors LLC

  Watch List News· 2026-04-16